ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $316,582 | -24.6% | 11,782 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $420,146 | +40.2% | 11,782 | -0.1% | 0.00% | +33.3% |
| Q1 2023 | $299,593 | +62576.4% | 11,795 | 0.0% | 0.00% | – |
| Q4 2022 | $478 | -99.9% | 11,795 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $390,000 | -3.5% | 11,795 | +2.7% | 0.00% | 0.0% |
| Q2 2022 | $404,000 | -23.9% | 11,482 | -0.5% | 0.00% | 0.0% |
| Q1 2022 | $531,000 | -30.7% | 11,544 | -0.1% | 0.00% | -33.3% |
| Q4 2021 | $766,000 | +7.3% | 11,557 | +1.0% | 0.01% | +20.0% |
| Q3 2021 | $714,000 | +7040.0% | 11,444 | +4897.4% | 0.01% | – |
| Q2 2020 | $10,000 | – | 229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |